Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,661 to 1,680 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML. | Cancer Manag Res | 2020 | 32099474 | PubTator, text mining | PubMed |
| Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma. | Int J Environ Res Public Health | 2020 | 32093341 | PubTator, text mining | PubMed |
| Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801. | Blood Adv | 2020 | 32092139 | PubTator, text mining | PubMed |
| Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia-related changes with mutated RUNX1. | Leuk Lymphoma | 2020 | 32091281 | PubTator, text mining | PubMed |
| CCAAT enhancer binding protein alpha (CEBPA) biallelic acute myeloid leukaemia: cooperating lesions, molecular mechanisms and clinical relevance. | Br J Haematol | 2020 | 32086816 | PubTator, text mining | PubMed |
| A Network Pharmacology Approach to Estimate the Active Ingredients and Potential Targets of Cuscutae semen in the Treatment of Osteoporosis. | Med Sci Monit | 2020 | 32081843 | PubTator, text mining | PubMed |
| Targeting DNA binding proteins for cancer therapy. | Cancer Sci | 2020 | 32073717 | PubTator, text mining | PubMed |
| Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia. | Hemasphere | 2020 | 32072137 | PubTator, text mining | PubMed |
| Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML. | J Biol Chem | 2020 | 32071087 | PubTator, text mining | PubMed |
| FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML. | Nat Commun | 2020 | 32066721 | PubTator, text mining | PubMed |
| Genetic basis for iMCD-TAFRO. | Oncogene | 2020 | 32051554 | PubTator, text mining | PubMed |
| Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors. | Chin Med J (Engl) | 2020 | 32044818 | PubTator, text mining | PubMed |
| Complex Interplay between the RUNX Transcription Factors and Wnt/β-Catenin Pathway in Cancer: A Tango in the Night. | Mol Cells | 2020 | 32041394 | PubTator, text mining | PubMed |
| The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling. | Blood Cancer J | 2020 | 32029705 | PubTator, text mining | PubMed |
| Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling. | Cell Signal | 2020 | 32027948 | PubTator, text mining | PubMed |
| [Relation of ASXL2 Gene Mutation with Clinical Characteristics, Prognosis and C-KIT Gene Mutation in AML Patients with AML1- ETO Fusion Gene]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2020 | 32027264 | PubTator, text mining | PubMed |
| [Effect of CD56 Expression on Prognosis of AML Patients with AML/ETO Mutation]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2020 | 32027254 | PubTator, text mining | PubMed |
| Clonal competition within complex evolutionary hierarchies shapes AML over time. | Nat Commun | 2020 | 32024830 | PubTator, text mining | PubMed |
| LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells. | Cell Death Dis | 2020 | 32024815 | PubTator, text mining | PubMed |
| Role of RUNX Family Transcription Factors in DNA Damage Response. | Mol Cells | 2020 | 32024352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=84